| ABSZX | ASVRX | ABSZX / ASVRX | |
| Total Expense Ratio | 0.81 | 1.58 | 51% |
| Annual Report Gross Expense Ratio | 0.81 | 1.58 | 51% |
| Fund Existence | 12 years | 16 years | - |
| Gain YTD | 3.725 | -3.131 | -119% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2000000 | 2500 | 80,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.33B | 3.99B | 58% |
| Annual Yield % from dividends | 0.78 | 0.42 | 185% |
| Returns for 1 year | -14.99 | -15.60 | 96% |
| Returns for 3 years | -1.16 | 2.33 | -50% |
| Returns for 5 years | 9.72 | 20.89 | 47% |
| Returns for 10 years | 14.49 | 12.42 | 117% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| PHLCX | 14.93 | 0.14 | +0.95% |
| PGIM Jennison Health Sciences C | |||
| SUIIX | 67.06 | 0.36 | +0.54% |
| DWS CROCI International Inst | |||
| FZALX | 30.94 | 0.14 | +0.45% |
| Fidelity Advisor Mega Cap Stock Z | |||
| DHIYX | 21.64 | 0.09 | +0.42% |
| Diamond Hill International Y | |||
| EEMIX | 10.17 | -0.01 | -0.10% |
| MFS Emerging Markets Equity Research I | |||